NMIH:NASDAQNMI Holdings Inc Analysis
Data as of 2026-04-20 - not real-time
$39.99
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
NMI Holdings (NMIH) trades at $39.99, well below its DCF fair value of $64.0 and a P/E of 8.1 versus an industry average of 17.7, indicating a substantial valuation gap. The stock sits just above the 20‑day SMA ($38.06) and below the 50‑day SMA ($38.64), with a neutral trend, while the MACD shows a bullish crossover (line 0.32 > signal 0.09) and RSI at 64.6 suggests upward momentum without being overbought. Volatility over the past 30 days is ~19.6% and beta is low at 0.49, pointing to modest market risk. Recent news highlights an upcoming Q1 earnings release on April 30 and a notable sale of $707K worth of shares by the executive chairman, providing mixed short‑term sentiment, yet the broader market sentiment is in “Extreme Greed” (FGI 87).
Overall, the company’s high gross (78%) and operating margins, solid cash flow, and a “Buy” consensus from analysts (7 votes) support a view that the stock is fundamentally strong but temporarily pressured, making it an attractive entry point for investors seeking upside potential.
Overall, the company’s high gross (78%) and operating margins, solid cash flow, and a “Buy” consensus from analysts (7 votes) support a view that the stock is fundamentally strong but temporarily pressured, making it an attractive entry point for investors seeking upside potential.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- Bullish MACD histogram and RSI indicating momentum
- Significant undervaluation versus DCF and industry P/E
- Upcoming earnings release could catalyze price movement
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustained high profit margins and strong operating cash flow
- Continued upside potential given 15.7% fair‑value upside
- Analyst consensus leaning toward a buy recommendation
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Low beta and moderate volatility support stability
- Elevated debt‑to‑equity ratio introduces leverage risk
- Potential regulatory and policy shifts in the specialty insurance space
Key Metrics & Analysis
Financial Health
Revenue Growth8.50%
Profit Margin55.05%
P/E Ratio8.1
ROE16.17%
ROA9.18%
Debt/Equity16.42
P/B Ratio1.2
Op. Cash Flow$419.3M
Free Cash Flow$267.1M
Industry P/E17.7
Technical Analysis
TrendNeutral
RSI64.6
Support$36.60
Resistance$40.31
MA 20$38.06
MA 50$38.64
MA 200$38.53
MACDBullish
VolumeDecreasing
Fear & Greed Index87.02
Valuation
Fair Value$64.03
Target Price$46.29
Upside/Downside15.74%
GradeUndervalued
TypeBlend
Risk Assessment
Beta0.49
Volatility19.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.